<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38055113</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1867-0687</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>World journal of pediatrics : WJP</Title><ISOAbbreviation>World J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Risk factors for long COVID in children and adolescents: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>133</StartPage><EndPage>142</EndPage><MedlinePgn>133-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12519-023-00765-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">The long-term sequelae of COVID-19 in children and adolescents remain poorly understood and characterized. This systematic review and meta-analysis sought to summarize the risk factors for long COVID in the pediatric population.</AbstractText><AbstractText Label="METHODS">We searched six databases from January 2020 to May 2023 for observational studies reporting on risk factors for long COVID or persistent symptoms those were present 12 or more weeks post-infection using multivariable regression analyses. Trial registries, reference lists of included studies, and preprint servers were hand-searched for relevant studies. Random-effects meta-analyses were conducted to pool odds ratios for each risk factor. Individual study risk of bias was rated using QUIPS, and the GRADE framework was used to assess the certainty of evidence for each unique factor.</AbstractText><AbstractText Label="RESULTS">Sixteen observational studies (N&#x2009;=&#x2009;46,262) were included, and 19 risk factors were amenable to meta-analysis. With moderate certainty in the evidence, age (per 2-year increase), allergic rhinitis, obesity, previous respiratory diseases, hospitalization, severe acute COVID-19, and symptomatic acute COVID-19 are probably associated with an increased risk of long COVID. Female sex, asthma, comorbidity, and heart diseases may be associated with an increased risk of long COVID, and Asian and Black races may be associated with a decreased risk of long COVID. We did not observe any credible subgroup effects for any risk factor.</AbstractText><AbstractText Label="CONCLUSIONS">The current body of literature presents several compelling risk factors for the development of long COVID in the pediatric population. Further research is necessary to elucidate the pathophysiology of long COVID.</AbstractText><CopyrightInformation>&#xa9; 2023. Children's Hospital, Zhejiang University School of Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rayner</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0001-6699-3090</Identifier><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada. rayned1@mcmaster.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Cloris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Om D</ForeName><Initials>OD</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aleluya</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giglia</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Science, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddique</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4K1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>World J Pediatr</MedlineTA><NlmUniqueID>101278599</NlmUniqueID></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Pediatrics</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38055113</ArticleId><ArticleId IdType="doi">10.1007/s12519-023-00765-z</ArticleId><ArticleId IdType="pii">10.1007/s12519-023-00765-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9:129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId><ArticleId IdType="pmc">7832375</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Coronavirus disease (COVID-19): post COVID-19 condition [Internet]. Switzerland: World Health Organization; 2023. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition .</Citation></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum. 2022;3:e221809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVries A, Shambhu S, Sloop S, Overhage JM. One-year adverse outcomes among US adults with post-COVID-19 condition vs those without COVID-19 in a large commercial insurance database. JAMA Health Forum. 2023;4:e230010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2023.0010</ArticleId><ArticleId IdType="pubmed">36867420</ArticleId><ArticleId IdType="pmc">9984976</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183:e230750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YB, Zeng N, Yuan K, Tian SS, Yang YB, Gao N, et al. Prevalence and risk factor for long COVID in children and adolescents: a meta-analysis and systematic review. J Infect Public Health. 2023;16:660&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId><ArticleId IdType="pmc">9990879</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, Zhang AXD, O&#x2019;Mahoney LL, Stephenson TJ, et al. Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84:158&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. New Jersey: Wiley; 2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470712184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, C&#xf4;t&#xe9; P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-4-201302190-00009</ArticleId><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>Foroutan F, Iorio A, Thabane L, Guyatt G. Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest. J Clin Epidemiol. 2020;117:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.08.012</ArticleId><ArticleId IdType="pubmed">31589954</ArticleId></ArticleIdList></Reference><Reference><Citation>Foroutan F, Guyatt G, Zuk V, Vandvik PO, Alba AC, Mustafa R, et al. GRADE Guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. J Clin Epidemiol. 2020;121:62&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.12.023</ArticleId><ArticleId IdType="pubmed">31982539</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ. 2015;350:h870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h870</ArticleId><ArticleId IdType="pubmed">25775931</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.05.006</ArticleId><ArticleId IdType="pubmed">28529184</ArticleId><ArticleId IdType="pmc">6542664</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler L, Israel M, Yehoshua I, Azuri J, Hoffman R, Shahar A, et al. Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study. BMJ Open. 2023;13:e064155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-064155</ArticleId><ArticleId IdType="pubmed">36810170</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Nemati H, Shahisavandi M, Akbari A, Emami A, Lotfi M, et al. Long COVID in children and adolescents. World J Pediatr. 2021;17:495&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId><ArticleId IdType="pmc">8414448</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison CJ, Whitaker M, Donnelly CA, Chadeau-Hyam M, Riley S, Darzi A, et al. Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: a large community cross-sectional study in England. Arch Dis Child. 2023. https://doi.org/10.1136/archdischild-2022-325152 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-325152</ArticleId><ArticleId IdType="pubmed">36863848</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, Pazukhina E, Ricchiuto A, Sinatti D, Zona M, et al. Post-COVID condition in adults and children living in the same household in Italy: a prospective cohort study using the ISARIC global follow-up protocol. Front Pediatr. 2022;10:834875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId><ArticleId IdType="pmc">9070551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertesv&#xe5;g NU, Iversen A, Blomberg B, &#xd6;zg&#xfc;m&#xfc;&#x15f; T, Rijal P, Fjelltveit EB, et al. Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. EBioMedicine. 2023;92:104599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104599</ArticleId><ArticleId IdType="pubmed">37149931</ArticleId><ArticleId IdType="pmc">10166589</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk AL, Kuppermann N, Florin TA, Tancredi DJ, Xie J, Kim K, et al. Post-COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw Open. 2022;5:e2223253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23253</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId><ArticleId IdType="pmc">9308058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostev K, Smith L, Koyanagi A, Konrad M, Jacob L. Post-COVID-19 conditions in children and adolescents diagnosed with COVID-19. Pediatr Res. 2022. https://doi.org/10.1038/s41390-022-02111-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02111-x</ArticleId><ArticleId IdType="pubmed">35568733</ArticleId><ArticleId IdType="pmc">9107066</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddux AB, Berbert L, Young CC, Feldstein LR, Zambrano LD, Kucukak S, et al. Health impairments in children and adolescents after hospitalization for acute COVID-19 or MIS-C. Pediatrics. 2022;150:e2022057798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-057798</ArticleId><ArticleId IdType="pubmed">35765138</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E, Weiss M, Krone B, Cohen S, Ilani G, Vinker S, et al. Clinical and socio-demographic variables associated with the diagnosis of long COVID syndrome in youth: a population-based study. Int J Environ Res Public Health. 2022;19:5993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19105993</ArticleId><ArticleId IdType="pubmed">35627530</ArticleId><ArticleId IdType="pmc">9141083</ArticleId></ArticleIdList></Reference><Reference><Citation>Messiah SE, Hao T, DeSantis SM, Swartz MD, Talebi Y, Kohl HW, et al. Comparison of persistent symptoms following SARS-CoV-2 infection by antibody status in nonhospitalized children and adolescents. Pediatr Infect Dis J. 2022;41:e409&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003653</ArticleId><ArticleId IdType="pubmed">35939608</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R, Mariani F, Mastrantoni L, De Rose C, Zampino G, Munblit D, et al. Risk factors for post-COVID-19 condition (long COVID) in children: a prospective cohort study. EClinicalMedicine. 2023;59:101961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId><ArticleId IdType="pmc">10101848</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for post-COVID-19 condition in previously hospitalized children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59:2101341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId><ArticleId IdType="pmc">8576804</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. Prevalence and risk factors for post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20:244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId><ArticleId IdType="pmc">9257572</ArticleId></ArticleIdList></Reference><Reference><Citation>Seery V, Raiden S, Penedo JMG, Borda M, Herrera L, Uranga M, Marc&#xf3; Del Pont M, et al. Persistent symptoms after COVID-19 in children and adolescents from Argentina. Int J Infect Dis. 2023;129:49&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.031</ArticleId><ArticleId IdType="pubmed">36736574</ArticleId><ArticleId IdType="pmc">9892252</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapani G, Verlato G, Bertino E, Maiocco G, Vesentini R, Spadavecchia A, et al. Long COVID-19 in children: an Italian cohort study. Ital J Pediatr. 2022;48:83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01282-x</ArticleId><ArticleId IdType="pubmed">35659358</ArticleId><ArticleId IdType="pmc">9163526</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizzari G, Morniroli D, Tiraferri V, Castaldi S, Patria MF, Marchisio P, et al. Modulating role of breastfeeding toward long COVID occurrence in children: a preliminary study. Front Pediatr. 2022;10:884962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.884962</ArticleId><ArticleId IdType="pubmed">35433541</ArticleId><ArticleId IdType="pmc">9005771</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, Choi SH, Yun KW. Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. J Korean Med Sci. 2022;37:e35.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e35</ArticleId><ArticleId IdType="pubmed">35132841</ArticleId><ArticleId IdType="pmc">8822112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadayon Najafabadi B, Rayner DG, Shokraee K, Shokraie K, Panahi P, Rastgou P, et al. Obesity as an independent risk factor for COVID-19 severity and mortality. Cochrane Database Syst Rev. 2023;5:CD015201.</Citation><ArticleIdList><ArticleId IdType="pubmed">37222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and COVID-19 risk: a systematic review and meta-analysis. Eur Respir J. 2022;59:2101209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01209-2021</ArticleId><ArticleId IdType="pubmed">34385278</ArticleId><ArticleId IdType="pmc">8361304</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Zhao H, Song Y, Zhou J, Wu T, Qiu J, et al. The association between allergic rhinitis and COVID-19: a systematic review and meta-analysis. Int J Clin Pract. 2022;2022:6510332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6510332</ArticleId><ArticleId IdType="pubmed">36249911</ArticleId><ArticleId IdType="pmc">9534623</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023;115:233&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Shortreed SM, Gray R, Akosile MA, Walker RL, Fuller S, Temposky L, et al. Increased COVID-19 infection risk drives racial and ethnic disparities in severe COVID-19 outcomes. J Racial Ethn Health Disparities. 2023;10:149&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-021-01205-2</ArticleId><ArticleId IdType="pubmed">35072944</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of COVID-19 vaccination on long COVID: systematic review. BMJ Med. 2023;2:e000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId><ArticleId IdType="pmc">9978692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>